Publications

February 2000 (Revised June 2003)
Case

Pepcid AC: Racing to the OTC Market

By: Charles King III, Alvin J. Silk, Ernst R. Berndt and Lisa R. Klein

Pepcid management must decide whether to risk all in a race to be first in the over-the-counter market with a new heartburn remedy. View Details

Keywords: Competitive Advantage; Product Positioning; Markets; Research; Marketing Strategy; Product Development; Decision Choices and Conditions; Pharmaceutical Industry

June 1999 (Revised October 1999)
Case

Eli Lilly, 1998 (B): Emerging Global Organization

By: Michael Y. Yoshino and Thomas W. Malnight

Examines major issues faced by Eli Lilly as it evaluates the appropriateness of a focused matrix organization with extensive use of cross-functional teams. View Details

Keywords: Business Model; Geography; Globalized Firms and Management; Growth and Development; Knowledge; Management Teams; Product; Organizations; Pharmaceutical Industry

October 1987 (Revised November 1994)
Case

Boston Fights Drugs (A): Designing Communications Research

By: V. Kasturi Rangan

Describes in detail the research mounted by five individuals with a $20,000 budget to combat drug abuse among Boston's school-going population. Using the focus group methodology they discover that most of the current anti-drug advertising is useless. They create their... View Details

Keywords: Budgets and Budgeting; Misleading and Fraudulent Advertising; Communication Intention and Meaning; Brands and Branding; Performance Evaluation; Research and Development; Segmentation; Pharmaceutical Industry; Boston

September 1983 (Revised October 1984)
Case

Syntex Laboratories (A)

A consulting project involving a mathematical model of the sales force indicates that Syntex Labs should nearly double the size of their sales force and drastically alter their allocation of sales effort to the product line and physician specialties. The questions are... View Details

Keywords: Organizational Change and Adaptation; Strategic Planning; Salesforce Management; Pharmaceutical Industry

March 1980 (Revised February 1984)
Case

Kramer Pharmaceuticals, Inc.

The 12-year career of Mr. Bob Marsh is traced, from recruitment to termination. Data on Kramer's sales management, performance evaluation, compensation, and sales training systems are given. View Details

Keywords: Personal Development and Career; Pharmaceutical Industry

01 Sep 2015
Blog Post

Building a Startup at HBS

prototype which we showcased at HBS and tested out in the NICU to observe its efficacy and nurse uptake. While we each embarked on different paths after the end of first year– from launching a new healthcare venture in Africa, to working at large View Details

Fast Answer

Transforming Health Care Delivery

Books Books and journal titles on all aspects of the health care, life sciences and pharmaceutical sectors View Details

05 Jan 2011
Op-Ed

Funding Unpredictability Around Stem-Cell Research Inflicts Heavy Cost on Scientific Progress

In light of the latest developments of the on-again, off-again, on-again government funding of human embryonic stem-cell research, it is time to consider the devastating implications of this chaotic funding environment. And to do that, one needs to understand how a... View Details

Keywords: by William Sahlman; Pharmaceutical; Pharmaceutical; Pharmaceutical

01 Jun 2009
Lessons from the Classroom

The Challenges of Investing in Science-Based Innovation

In economic downtimes, businesses are apt to cut R&D projects that don't promise a speedy return on investment. But take a cue from smart science-based businesses, which view the recession as an opportunity to stoke up research and innovation for long-term... View Details

Keywords: by Julia Hanna; Pharmaceutical; Pharmaceutical; Pharmaceutical

28 Sep 2020
Working Paper Summaries

What Can Economics Say About Alzheimer's Disease?

Keywords: by Amitabh Chandra, Courtney Coile, and Corina Mommaerts; Pharmaceutical; Pharmaceutical

09 Jun 2020
Cold Call Podcast

In a Pandemic, What’s the Best Strategy for the Global Vaccine Alliance?

Keywords: Re: Tarun Khanna; Pharmaceutical; Pharmaceutical

March 2025
Teaching Note

Gavi and the 'Next' Pandemic

By: Tarun Khanna and Samir Junnarkar

Teaching Note for HBS Case No. 725-351. View Details

Keywords: Pharmaceutical Industry; Africa

August 2024
Article

How Do Copayment Coupons Affect Branded Drug Prices and Quantities Purchased?

By: Leemore S. Dafny, Kate Ho and Edward Kong

Drug copayment coupons to reduce patient cost-sharing have become nearly ubiquitous for high-priced brand-name prescription drugs. Medicare bans such coupons on the grounds that they are kickbacks that induce utilization, but they are commonly used by... View Details

Keywords: Prescription Drugs; Coupons; Impact; Health Care and Treatment; Markets; Price; Spending; Pharmaceutical Industry; United States

Find at Harvard

Register to Read

Forthcoming
Article

Regulatory Incentives for Innovation: The FDA's Breakthrough Therapy Designation

By: Amitabh Chandra, Jennifer Kao, Kathleen L. Miller and Ariel Dora Stern

Regulators of new products confront a tradeoff between speeding a product to market and collecting additional product quality information. The FDA's Breakthrough Therapy Designation (BTD) provides an opportunity to understand if regulators can use new policy to... View Details

Keywords: Innovation and Invention; Governing Rules, Regulations, and Reforms; Government Administration; Research and Development; Pharmaceutical Industry

Find at Harvard

Register to Read

February 2024
Teaching Note

Compass Pathways: Pioneering Psychedelic Treatment

By: Tiona Zuzul

Teaching Note for HBS Case No. 724-412. View Details

Keywords: Commercialization; Corporate Strategy; Competitive Strategy; Product Launch; Health Care and Treatment; Pharmaceutical Industry; Europe; United States; United Kingdom

May 2023
Case

Legacy Partners

By: Royce Yudkoff and Richard S. Ruback

Stephen Holbrook and Austin Pulsipher (both HBS '19) had been leading Nutrishare since acquiring the company six months earlier in mid-2021. The company, based in Sacramento CA, was a compounding pharmacy serving Total Parenteral Nutrition ("TPN") patients nationwide.... View Details

Keywords: Acquisition; Growth and Development Strategy; Competitive Strategy; Business or Company Management; Pharmaceutical Industry

May 4, 2023
Article

Falling Insulin Prices—What Just Happened?

By: Leemore S. Dafny

Recently, more than 100 years after insulin was developed, manufacturers announced price reductions for insulin products. Pressure to reduce prices had long been building, so why would they act now? View Details

Keywords: Price; Health Care and Treatment; Public Opinion; Demand and Consumers; Pharmaceutical Industry